These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16044573)

  • 21. The therapeutic phase I trial of the recombinant native HIV-1 Tat protein.
    Ensoli B; Fiorelli V; Ensoli F; Lazzarin A; Visintini R; Narciso P; Di Carlo A; Monini P; Magnani M; Garaci E
    AIDS; 2008 Oct; 22(16):2207-9. PubMed ID: 18832884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vaccinations of HIV-infected travelers].
    Couzigou C; Voyer C; Shaghaghi CK; Bourée P; Vittecoq D
    Med Mal Infect; 2009 Jan; 39(1):21-8. PubMed ID: 18723304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of antiretroviral immunotherapy trials with potentially non-normal and incomplete longitudinal data.
    Mogg R; Mehrotra DV
    Stat Med; 2007 Feb; 26(3):484-97. PubMed ID: 16625520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies.
    Khurana S; Needham J; Mathieson B; Rodriguez-Chavez IR; Catanzaro AT; Bailer RT; Kim J; Polonis V; Cooper DA; Guerin J; Peterson ML; Gurwith M; Nguyen N; Graham BS; Golding H
    J Virol; 2006 Mar; 80(5):2092-9. PubMed ID: 16474117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines.
    Albert J; Chiodi F; Fenyö EM
    J Intern Med; 2007 Jul; 262(1):2-4. PubMed ID: 17598811
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert.
    Kim HN; Tabet SR; Corey L; Celum CL
    Vaccine; 2006 Jan; 24(4):532-9. PubMed ID: 16242816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccines. Vaccines as therapy.
    TreatmentUpdate; 2005; 17(1):9-10. PubMed ID: 17228403
    [No Abstract]   [Full Text] [Related]  

  • 28. Approaches for therapeutic vaccination in HIV infection.
    Stebbing J
    J HIV Ther; 2005 Sep; 10(3):46-7. PubMed ID: 16385970
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.
    Füst G
    Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dendritic cell vaccine is a hope for alternative treatment of HIV infection].
    Kahl U
    Lakartidningen; 2003 Jun; 100(25):2224. PubMed ID: 12872511
    [No Abstract]   [Full Text] [Related]  

  • 31. Large US study of HIV vaccine is halted because of lack of efficacy.
    McCarthy M
    BMJ; 2013 Apr; 346():f2734. PubMed ID: 23628751
    [No Abstract]   [Full Text] [Related]  

  • 32. AIDS clinical research for New Yorkers.
    GMHC Treat Issues; 2001 May; 15(5):11. PubMed ID: 11548300
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of predictive markers of HIV disease progression in vaccine trials.
    Gurunathan S; Habib RE; Baglyos L; Meric C; Plotkin S; Dodet B; Corey L; Tartaglia J
    Vaccine; 2009 Mar; 27(14):1997-2015. PubMed ID: 19200450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fc receptor but not complement binding is important in antibody protection against HIV.
    Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
    Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising leads opening up with vaccine research. One route involves neutralizing antibodies.
    AIDS Alert; 2009 Nov; 24(11):123-5. PubMed ID: 19960606
    [No Abstract]   [Full Text] [Related]  

  • 36. B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.
    Cagigi A; Nilsson A; De Milito A; Chiodi F
    Vaccine; 2008 Jun; 26(24):3016-25. PubMed ID: 18164520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic vaccination for HIV disease.
    Laurence J; Johnston R
    AIDS Read; 2003 Jun; 13(6):252-3, 260. PubMed ID: 12846168
    [No Abstract]   [Full Text] [Related]  

  • 38. Possible HIV vaccine stirs hope.
    Dent Today; 1997 Jan; 16(1):35. PubMed ID: 9560624
    [No Abstract]   [Full Text] [Related]  

  • 39. On the trail of a vaccine. An interview with David M. Gold, J.D. Interview by David Pieribone.
    Gold DM
    Posit Living; 2002; 11(5):15-9. PubMed ID: 12422821
    [No Abstract]   [Full Text] [Related]  

  • 40. Bringing the path toward an HIV-1 vaccine into focus.
    Lopez Angel CJ; Tomaras GD
    PLoS Pathog; 2020 Sep; 16(9):e1008663. PubMed ID: 32913360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.